<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(6)</volume><submitter>Leung WCY</submitter><pubmed_abstract>Although Coronavirus disease 2019 (COVID-19) vaccinations are generally recommended for persons with epilepsy (PwE), a significant vaccination gap remains due to patient concerns over the risk of post-vaccination seizure aggravation (PVSA). In this single-centre, retrospective cohort study, we aimed to determine the early (7-day) and delayed (30-day) risk of PVSA, and to identify clinical predictors of PVSA among PwE. Adult epilepsy patients aged ≥18 years without a history of COVID-19 infection were recruited from a specialty epilepsy clinic in early 2022. Demographic, epilepsy characteristics, and vaccination data were extracted from a centralized electronic patient record. Seizure frequency before and after vaccination, vaccination-related adverse effects, and reasons for or against vac</pubmed_abstract><journal>Vaccines</journal><pagination>593</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11209536</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Risk of Seizure Aggravation after COVID-19 Vaccinations in Patients with Epilepsy.</pubmed_title><pmcid>PMC11209536</pmcid><pubmed_authors>Chui JHY</pubmed_authors><pubmed_authors>Yeung EHL</pubmed_authors><pubmed_authors>Teo KC</pubmed_authors><pubmed_authors>Chan CYC</pubmed_authors><pubmed_authors>Leung AK</pubmed_authors><pubmed_authors>Chan AA</pubmed_authors><pubmed_authors>Chu FH</pubmed_authors><pubmed_authors>Li WTV</pubmed_authors><pubmed_authors>Leung WCY</pubmed_authors><pubmed_authors>Lo CNR</pubmed_authors><pubmed_authors>Chang RS</pubmed_authors><pubmed_authors>Ho RW</pubmed_authors><pubmed_authors>Lau GK</pubmed_authors><pubmed_authors>Chan DYH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Risk of Seizure Aggravation after COVID-19 Vaccinations in Patients with Epilepsy.</name><description>Although Coronavirus disease 2019 (COVID-19) vaccinations are generally recommended for persons with epilepsy (PwE), a significant vaccination gap remains due to patient concerns over the risk of post-vaccination seizure aggravation (PVSA). In this single-centre, retrospective cohort study, we aimed to determine the early (7-day) and delayed (30-day) risk of PVSA, and to identify clinical predictors of PVSA among PwE. Adult epilepsy patients aged ≥18 years without a history of COVID-19 infection were recruited from a specialty epilepsy clinic in early 2022. Demographic, epilepsy characteristics, and vaccination data were extracted from a centralized electronic patient record. Seizure frequency before and after vaccination, vaccination-related adverse effects, and reasons for or against vac</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2025-04-04T21:22:13.52Z</modification><creation>2025-04-04T21:22:13.52Z</creation></dates><accession>S-EPMC11209536</accession><cross_references><pubmed>38932322</pubmed><doi>10.3390/vaccines12060593</doi></cross_references></HashMap>